Related Experiment Video
Updated: Jun 20, 2026

Removal of an Internal Translational Start Site from mRNA While Retaining Expression of the Full-Length Protein
Published on: March 16, 2022
Genetic or pharmacological disruption of the MSH3 Y245/K246 IDL binding pocket slows CAG repeat expansion
Rob Goold1,2, Jasmine Donaldson1,2, Florence Gidney1,2
1Huntington's Disease Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, United Kingdom.
Abstract:
Recent genetic studies have shown somatic expansion of the CAG repeat is the key process driving Huntington's disease (HD) pathogenesis. Recognition of insertion-deletion loops (IDLs), lesions prone to form within the CAG repeat, by Mutsβ (MSH3/MSH2) is thought to be the primary event in the expansion process. This starts a cascade that leads to error-prone repair and incorporation of additional CAG units into the repeat. In vitro data shows MSH3 binds IDLs through a DNA-binding pocket formed by MSH3 residues Y245/K246. In this study, we investigated the significance of this DNA-binding motif in CAG repeat expansion using cell lines harbouring long, unstable HTT CAG repeats. Genetic disruption of the MSH3 Y245/K246 motif significantly reduced DNA interaction, exhibited MMR deficiency in a frameshift mutator assay, and abrogated repeat expansion in a U2OS cell line expressing mutant HTT exon 1. Pharmacological blockade of this site using a small molecule targeting the DNA-binding pocket similarly reduced DNA binding and repeat expansion in a U2OS cell line. Crucially, this molecule also slowed CAG repeat expansion in medium spiny neurones derived from HD patient-iPSCs. Targeting of the MSH3 IDL binding pocket may represent a possible therapeutic strategy.
Insights
Targeting the MSH3 protein
Area of Science:
- Genetics
- Molecular Biology
- Neuroscience
Background:
- Somatic expansion of CAG repeats drives Huntington's disease (HD) pathogenesis.
- MSH3/MSH2 (Mutsβ) recognizes insertion-deletion loops (IDLs) in CAG repeats, initiating expansion.
- MSH3 binds IDLs via a pocket formed by Y245/K246 residues.
Purpose of the Study:
- Investigate the role of the MSH3 Y245/K246 DNA-binding motif in CAG repeat expansion.
- Assess the therapeutic potential of targeting this MSH3 binding pocket.
Main Methods:
- Utilized cell lines with long, unstable HTT CAG repeats.
- Genetically disrupted the MSH3 Y245/K246 motif.
- Employed a small molecule to pharmacologically block the MSH3 DNA-binding pocket.
- Assessed MSH3 DNA interaction, mismatch repair (MMR) deficiency, and repeat expansion.
- Tested the molecule in patient-derived induced pluripotent stem cell (iPSC) neurons.
Main Results:
- Disruption of the MSH3 Y245/K246 motif reduced DNA interaction and abrogated CAG repeat expansion.
- Genetic disruption led to MMR deficiency.
- Pharmacological blockade of the MSH3 binding pocket reduced DNA binding and repeat expansion in cell lines.
- The small molecule slowed CAG repeat expansion in HD patient-derived neurons.
Conclusions:
- The MSH3 Y245/K246 motif is crucial for MSH3's role in CAG repeat expansion.
- Targeting the MSH3 IDL binding pocket with small molecules is a viable therapeutic strategy for Huntington's disease.
- This approach shows promise for slowing disease progression in patient-specific cells.
Related Concept Videos
Restarting Stalled Replication Forks
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mismatch Repair
Abnormal Proliferation

